ATE57933T1 - Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe. - Google Patents

Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe.

Info

Publication number
ATE57933T1
ATE57933T1 AT87102447T AT87102447T ATE57933T1 AT E57933 T1 ATE57933 T1 AT E57933T1 AT 87102447 T AT87102447 T AT 87102447T AT 87102447 T AT87102447 T AT 87102447T AT E57933 T1 ATE57933 T1 AT E57933T1
Authority
AT
Austria
Prior art keywords
complexes
platia
tetrahydro
diamine
heterocyclic
Prior art date
Application number
AT87102447T
Other languages
English (en)
Inventor
Panayota Bitha
Ralph Grassing Child
Joseph John Hlavka
Yang-I Lin
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE57933T1 publication Critical patent/ATE57933T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87102447T 1986-03-20 1987-02-20 Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe. ATE57933T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/841,647 US4716157A (en) 1986-03-20 1986-03-20 Heterocyclic-1,2-diamine platinum complexes
EP87102447A EP0237829B1 (de) 1986-03-20 1987-02-20 Heterocyclische Tetrahydro-3,4-diamin-N-N'-platin-Komplexe

Publications (1)

Publication Number Publication Date
ATE57933T1 true ATE57933T1 (de) 1990-11-15

Family

ID=25285372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87102447T ATE57933T1 (de) 1986-03-20 1987-02-20 Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe.

Country Status (8)

Country Link
US (1) US4716157A (de)
EP (1) EP0237829B1 (de)
JP (1) JPS62289591A (de)
AT (1) ATE57933T1 (de)
CA (1) CA1282060C (de)
DE (1) DE3765808D1 (de)
ES (1) ES2020953B3 (de)
GR (1) GR3001035T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970324A (en) * 1985-12-24 1990-11-13 Hoeschele James D Aminoalkyl-substituted azetidine platinum(II) complexes
US5116831A (en) * 1985-12-24 1992-05-26 Warner-Lambert Company Aminoalkyl-substituted cycloalkylamine platinum (II) complexes
US4870070A (en) * 1987-08-10 1989-09-26 American Cyanamid Company Water soluble platinum complexes of novel malonate derivatives
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5214174A (en) * 1989-12-15 1993-05-25 Tsumura & Co. Platinum complex and anti-tumor agent comprising said complex as active ingredient
JPH09316065A (ja) * 1996-05-31 1997-12-09 Nikko Rika Kk １，４−アンヒドロ−２−デオキシ−ｄ−エリトロ−ペンチトールの製造法
DE10226592B4 (de) * 2002-06-14 2004-07-29 Faustus Forschungs Cie. Translational Cancer Research Gmbh Tumorhemmende Platin(II)-oxalato-Komplexe
US8895610B1 (en) 2007-05-18 2014-11-25 Heldi Kay Platinum (IV) compounds targeting zinc finger domains
WO2008144616A1 (en) 2007-05-18 2008-11-27 Heidi Kay Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
NL8101026A (nl) * 1981-03-03 1982-10-01 Tno Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel.
US4500465A (en) * 1982-06-28 1985-02-19 Engelhard Corporation Solubilized platinum (II) complexes
IL67789A (en) * 1983-01-31 1986-09-30 Yissum Res Dev Co Amino-substituted malonato platinum(ii)complexes and method for their preparation
US4661516A (en) * 1983-06-20 1987-04-28 Research Corporation Diaminocyclohexane platinum complexes
WO1985003296A1 (en) * 1984-01-23 1985-08-01 Institut Obschei I Neorganicheskoi Khimii Imeni N. Blended carboxylate complexes of platinum

Also Published As

Publication number Publication date
ES2020953B3 (es) 1991-10-16
CA1282060C (en) 1991-03-26
JPS62289591A (ja) 1987-12-16
US4716157A (en) 1987-12-29
GR3001035T3 (en) 1992-01-20
DE3765808D1 (de) 1990-12-06
EP0237829A3 (en) 1988-01-07
EP0237829B1 (de) 1990-10-31
EP0237829A2 (de) 1987-09-23

Similar Documents

Publication Publication Date Title
FI932032A0 (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
FI872432A0 (fi) Indirekt kolorimetrisk bestaemning av en analyt i ett prov med hjaelp av ljussignalers foerhaollande.
DE68922314T3 (de) Synergetische brennstoffzusammensetzung.
DE59104440D1 (de) Epiduralkanüle.
DE68908248T2 (de) Kathodische Elektrotauchlackierungszusammensetzungen.
DE3788525T2 (de) Feldeffekttransistoranordnungen.
FI871632A (fi) Heterocykliska karboxamider.
DE3870959D1 (de) 2-difluormethoxy-1,1,1,2-tetrafluoraethan als anaesthetikum.
IT8720200A0 (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine.
DE3876490D1 (de) Korrosionsinhibierende zusammensetzung.
ATE57933T1 (de) Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe.
FI904676A0 (fi) Anordning foer loesgoerande av manteln i en haeftapparat.
DE3767728D1 (en) Hydroxylierte 1,2-diamincyclohexan platinkomplexe.
FI863006A0 (fi) Foerfarande foer framstaellning av metanol i en vaetskefas.
DE3851991T2 (de) Bipolartransistoren.
FI880745A0 (fi) Hot-melt-limblandning foer foersaettsblad i boecker med haorda paermar.
DE3788942T2 (de) Gleitteile.
ATE67992T1 (de) In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften.
EP0304566A3 (de) Wasserlösliche Platinkomplexe von Malonsäure-Derivaten
DE3881991T2 (de) Zusammensetzung von Gleitgliedern.
DE3884300T2 (de) Magnetische Polymerzusammensetzungen.
ES2053808T3 (es) Nuevos compuestos azolicos.
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
ATE102035T1 (de) Verwendung von 5-heteroaryl- oder 5arylsubstituierten imidazo(2,1-a)isochinolinen.
SU1136450A1 (ru) 4-(2'-Нафтиламино-4'-хлорфенил)-метилантипирин, проявляющий анальгетическую активность

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee